Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Data Regulatory News (MAST)

  • There is currently no data for MAST

MED Binding JVA Completion Update

22 Sep 2023 07:00

RNS Number : 2868N
Mast Energy Developments PLC
22 September 2023
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

Dated: 22 September 2023

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

MED Binding Joint Venture Agreement Completion Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer and operator in the rapidly growing flexible power market, announces that further to its previous announcements dated 12 July 2023, 4 August 2023, and 1 September 2023 respectively, it has further extended the completion long-stop date for the first definitive and binding Joint Venture Agreement ('JVA'). Completion is now expected around mid-October 2023. The further extension is required to allow the JV investor consortium to complete the compulsory statutory process, as set out in the announcement of 1 September 2023. This process and timelines associated therewith remains beyond the control of the Company and the JV investor who remains fully committed to see this completed at the earliest possible date.

 

Although MED is continuing to work with the investor consortium, and the board have full confidence that the transaction will be completed, unless or until the first definitive and binding Joint Venture Agreement ('JVA') has been completed, Seira Capital Ltd ('Seira') remains contractually bound under the JVA, and remains in breach of its obligations thereto. Should the investor consortium fail to complete the transaction around the latest completion extension date, MED will consider all its options, including but not limited to commencing legal proceedings against Seira and affected parties, as well as alternative investment opportunities.

 

Pieter Krügel, CEO of MED, commented: "We remain confident that the investor consortium will be able to complete the transaction and the board have also received written reassurance from the investor consortium in this regard."

 

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

 

Pieter Krügel

Info@med.energy

Mast Energy

Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor & Media Relations Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEMFAFEDSEDU
Date   Source Headline
11th Feb 20257:00 amRNSRecord High January Revenues
27th Jan 20257:00 amRNSNew Website Launch
13th Jan 20257:00 amRNSRecord High Sales Price Achieved
19th Dec 20247:00 amRNSCompany Update
3rd Dec 20247:00 amRNSCompany Update
22nd Nov 20247:00 amRNSOperating & Corporate Update
14th Oct 202412:30 pmRNSHolding(s) in Company
10th Oct 202412:20 pmRNSHolding(s) in Company
8th Oct 202412:30 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSRecord High September Revenues
1st Oct 20248:00 amRNSShares Lock-in Agreement & Pyebridge Update
12th Sep 20247:00 amRNSPyebridge Revenue Updates
30th Aug 20247:00 amRNSHalf-year Report
20th Aug 20247:00 amRNSBusiness Update
13th Aug 202412:30 pmRNSTR-1 Notification
8th Aug 20244:30 pmRNSTR-1 Notification
7th Aug 20247:00 amRNSPyebridge Revenue Update re Refurbished Genset
31st Jul 20243:00 pmRNSTR-1 Notification
30th Jul 20247:00 amRNSTR1 Notification
1st Jul 20247:00 amRNSRevenue Generation & Potential Acquisition
13th Jun 20247:00 amRNSBusiness Update
5th Jun 20241:22 pmRNSHolding(s) in Company
30th May 20242:00 pmRNSResult of AGM
29th May 20249:11 amRNSHolding(s) in Company
23rd May 20243:55 pmRNSCapitalisation of Loan Update
21st May 20247:00 amRNSBusiness Update
9th May 202410:45 amRNSHolding(s) in Company
8th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSUpdate, Loan Capitalisation & Equity Issue
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
26th Apr 20247:00 amRNSBusiness Update
23rd Apr 20242:30 pmRNSHolding(s) in Company TR 1
11th Apr 20247:00 amRNSBusiness Update
7th Mar 20248:06 amRNSQ1 2024 Corporate Presentation
4th Mar 202410:45 amRNSHolding(s) in Company
28th Feb 20247:00 amRNSFunding Partner, Agreement & Proventure Terminated
20th Feb 20241:00 pmRNSTR-1: Standard form notification of major holdings
5th Feb 20241:55 pmRNSTR-1: Standard form notification of major holdings
24th Jan 20243:45 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSMED Binding JVA Progress Update
2nd Jan 20247:00 amRNSMED Binding JVA Completion Update
22nd Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Dec 20237:00 amRNSDirector Loan & PDMR Share Sale
11th Dec 20237:52 amRNSMED Binding JVA Update
11th Dec 20237:00 amRNSMED Binding JVA Completion Update
5th Dec 20234:30 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Nov 20233:31 pmRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSMED Binding JVA Interim Payment Update
26th Oct 202310:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.